 | • レポートコード：QYR9ST05940 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ダラツムマブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、100mg注射、400mg注射に、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、濾胞性リンパ腫、マントル細胞リンパ腫、その他にセグメント区分し、ダラツムマブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ダラツムマブの世界市場概要 ・ダラツムマブの製造コスト構成分析 ・ダラツムマブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ダラツムマブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ダラツムマブのセグメント分析（種類別） （100mg注射、400mg注射） ・ダラツムマブのセグメント分析（用途別） （多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、濾胞性リンパ腫、マントル細胞リンパ腫、その他） ・ダラツムマブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Johnson＆Johnson） ・ダラツムマブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Daratumumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Daratumumab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Daratumumab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Daratumumab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Daratumumab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson＆Johnson
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
100mg Injection
400mg Injection
Segment by Application
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Daratumumab
1.1 Definition of Daratumumab
1.2 Daratumumab Segment by Type
1.2.1 Global Daratumumab Production Growth Rate Comparison by Types (2014-2025)
1.2.2 100mg Injection
1.2.3 400mg Injection
1.3 Daratumumab Segment by Applications
1.3.1 Global Daratumumab Consumption Comparison by Applications (2014-2025)
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Mantle Cell Lymphoma
1.3.6 Other
1.4 Global Daratumumab Overall Market
1.4.1 Global Daratumumab Revenue (2014-2025)
1.4.2 Global Daratumumab Production (2014-2025)
1.4.3 North America Daratumumab Status and Prospect (2014-2025)
1.4.4 Europe Daratumumab Status and Prospect (2014-2025)
1.4.5 China Daratumumab Status and Prospect (2014-2025)
1.4.6 Japan Daratumumab Status and Prospect (2014-2025)
1.4.7 Southeast Asia Daratumumab Status and Prospect (2014-2025)
1.4.8 India Daratumumab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Daratumumab
2.3 Manufacturing Process Analysis of Daratumumab
2.4 Industry Chain Structure of Daratumumab
3 Development and Manufacturing Plants Analysis of Daratumumab
3.1 Capacity and Commercial Production Date
3.2 Global Daratumumab Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Daratumumab
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Daratumumab Production and Capacity Analysis
4.2 Daratumumab Revenue Analysis
4.3 Daratumumab Price Analysis
4.4 Market Concentration Degree
5 Daratumumab Regional Market Analysis
5.1 Daratumumab Production by Regions
5.1.1 Global Daratumumab Production by Regions
5.1.2 Global Daratumumab Revenue by Regions
5.2 Daratumumab Consumption by Regions
5.3 North America Daratumumab Market Analysis
5.3.1 North America Daratumumab Production
5.3.2 North America Daratumumab Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Daratumumab Import and Export
5.4 Europe Daratumumab Market Analysis
5.4.1 Europe Daratumumab Production
5.4.2 Europe Daratumumab Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Daratumumab Import and Export
5.5 China Daratumumab Market Analysis
5.5.1 China Daratumumab Production
5.5.2 China Daratumumab Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Daratumumab Import and Export
5.6 Japan Daratumumab Market Analysis
5.6.1 Japan Daratumumab Production
5.6.2 Japan Daratumumab Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Daratumumab Import and Export
5.7 Southeast Asia Daratumumab Market Analysis
5.7.1 Southeast Asia Daratumumab Production
5.7.2 Southeast Asia Daratumumab Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Daratumumab Import and Export
5.8 India Daratumumab Market Analysis
5.8.1 India Daratumumab Production
5.8.2 India Daratumumab Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Daratumumab Import and Export
6 Daratumumab Segment Market Analysis (by Type)
6.1 Global Daratumumab Production by Type
6.2 Global Daratumumab Revenue by Type
6.3 Daratumumab Price by Type
7 Daratumumab Segment Market Analysis (by Application)
7.1 Global Daratumumab Consumption by Application
7.2 Global Daratumumab Consumption Market Share by Application (2014-2019)
8 Daratumumab Major Manufacturers Analysis
8.1 Johnson＆Johnson
8.1.1 Johnson＆Johnson Daratumumab Production Sites and Area Served
8.1.2 Johnson＆Johnson Product Introduction, Application and Specification
8.1.3 Johnson＆Johnson Daratumumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
9 Development Trend of Analysis of Daratumumab Market
9.1 Global Daratumumab Market Trend Analysis
9.1.1 Global Daratumumab Market Size (Volume and Value) Forecast 2019-2025
9.2 Daratumumab Regional Market Trend
9.2.1 North America Daratumumab Forecast 2019-2025
9.2.2 Europe Daratumumab Forecast 2019-2025
9.2.3 China Daratumumab Forecast 2019-2025
9.2.4 Japan Daratumumab Forecast 2019-2025
9.2.5 Southeast Asia Daratumumab Forecast 2019-2025
9.2.6 India Daratumumab Forecast 2019-2025
9.3 Daratumumab Market Trend (Product Type)
9.4 Daratumumab Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Daratumumab Distributors List
10.3 Daratumumab Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Daratumumab
Table Global Daratumumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Daratumumab Production Market Share by Types in 2018
Figure 100mg Injection Product Picture
Figure 400mg Injection Product Picture
Table Global Daratumumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Daratumumab Consumption Market Share by Applications in 2018
Figure Multiple Myeloma
Figure Diffuse Large B Cell Lymphoma
Figure Follicular Lymphoma
Figure Mantle Cell Lymphoma
Figure Other
Figure Global Daratumumab Revenue (Million USD) (2014-2025)
Figure Global Daratumumab Production (K Pcs) (2014-2025)
Figure North America Daratumumab Market Size (Million USD) (2014-2025)
Figure Europe Daratumumab Market Size (Million USD) (2014-2025)
Figure China Daratumumab Market Size (Million USD) (2014-2025)
Figure Japan Daratumumab Market Size (Million USD) (2014-2025)
Figure Southeast Asia Daratumumab Market Size (Million USD) (2014-2025)
Figure India Daratumumab Market Size (Million USD) (2014-2025)
Table Daratumumab Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Daratumumab in 2018
Figure Manufacturing Process Analysis of Daratumumab
Figure Industry Chain Structure of Daratumumab
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Daratumumab Manufacturing Plants Distribution
Table Daratumumab Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Daratumumab Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Daratumumab Production (K Pcs) of Major Manufacturers (2014-2019)
Table Daratumumab Production Market Share of Major Manufacturers (2014-2019)
Figure Daratumumab Production Share by Manufacturers in 2018
Table Daratumumab Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Daratumumab Revenue Market Share of Major Manufacturers (2014-2019)
Figure Daratumumab Revenue Share by Manufacturers in 2018
Table Daratumumab Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Daratumumab Production by Regions 2014-2019 (K Pcs)
Table Global Daratumumab Production Market Share by Regions 2014-2019
Figure Global Daratumumab Production Market Share by Regions in 2018
Table Global Daratumumab Revenue by Regions 2014-2019 (Million USD)
Table Global Daratumumab Revenue Market Share by Regions 2014-2019
Figure Global Daratumumab Revenue Market Share by Regions in 2018
Table Global Daratumumab Consumption by Regions 2014-2019 (K Pcs)
Table Global Daratumumab Consumption Market Share by Regions 2014-2019
Figure North America Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure North America Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table North America Daratumumab Production, Consumption Import and Export (K Pcs)
Figure Europe Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Daratumumab Production, Consumption Import and Export (K Pcs)
Figure China Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure China Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table China Daratumumab Production, Consumption Import and Export (K Pcs)
Figure Japan Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Daratumumab Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Daratumumab Production, Consumption Import and Export (K Pcs)
Figure India Daratumumab Production Growth Rate 2014-2019 (K Pcs)
Figure India Daratumumab Revenue Growth Rate 2014-2019 (Million USD)
Table India Daratumumab Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Daratumumab Market Share by Application (2014-2019)
Figure Global Value (Consumption) Daratumumab Market Share by Application (2014-2019)
Table Johnson＆Johnson Daratumumab Production Sites and Area Served
Table Johnson＆Johnson Daratumumab Product Introduction, Application and Specification
Table Johnson＆Johnson Daratumumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson＆Johnson Daratumumab Production Growth Rate (2014-2019)
Table Johnson＆Johnson Daratumumab Production Market Share (2014-2019)
Figure Johnson＆Johnson Daratumumab Revenue Market Share (2014-2019)
Table Johnson＆Johnson Daratumumab Main Business and Markets Served
Figure Global Daratumumab Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Daratumumab Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Daratumumab Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Daratumumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Daratumumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Daratumumab by Type (2019-2025)
Table Global Consumption (K Pcs) of Daratumumab by Application (2019-2025)
Table Daratumumab Distributors List
Table Daratumumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のダラツムマブ市場：専門的調査 The global Daratumumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Daratumumab volume and value at global level, regional level and company level. From a global perspective, this repor…- 多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- ホジキンリンパ腫治療の世界市場：市場規模・現状・予測 Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- バーキットリンパ腫治療の世界市場：市場規模・現状・予測 Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreo…
- 非ホジキンリンパ腫治療の世界市場：市場規模・現状・予測 Non-Hodgkin lymphoma (NHL) is a condition where abnormal lymphocytes are produced in the human body. These lymphocytes do not die and keep growing and dividing within the body unless treated. NHL is generally located at lymph nodes, however, if not treated in time then it might spread to the entire …